411 related articles for article (PubMed ID: 24631770)
1. Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs.
Schuetze KB; McKinsey TA; Long CS
J Mol Cell Cardiol; 2014 May; 70():100-7. PubMed ID: 24631770
[TBL] [Abstract][Full Text] [Related]
2. The Crosstalk between Acetylation and Phosphorylation: Emerging New Roles for HDAC Inhibitors in the Heart.
Habibian J; Ferguson BS
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597863
[TBL] [Abstract][Full Text] [Related]
3. Non-sirtuin histone deacetylases in the control of cardiac aging.
Ferguson BS; McKinsey TA
J Mol Cell Cardiol; 2015 Jun; 83():14-20. PubMed ID: 25791169
[TBL] [Abstract][Full Text] [Related]
4. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
Hutt DM; Roth DM; Marchal C; Bouchecareilh M
Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylases in cardiac fibrosis: current perspectives for therapy.
Tao H; Shi KH; Yang JJ; Huang C; Zhan HY; Li J
Cell Signal; 2014 Mar; 26(3):521-7. PubMed ID: 24321371
[TBL] [Abstract][Full Text] [Related]
6. Chromatin modifications remodel cardiac gene expression.
Mathiyalagan P; Keating ST; Du XJ; El-Osta A
Cardiovasc Res; 2014 Jul; 103(1):7-16. PubMed ID: 24812277
[TBL] [Abstract][Full Text] [Related]
7. Food Bioactive HDAC Inhibitors in the Epigenetic Regulation of Heart Failure.
Evans LW; Ferguson BS
Nutrients; 2018 Aug; 10(8):. PubMed ID: 30126190
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibition attenuates cardiac hypertrophy and fibrosis through acetylation of mineralocorticoid receptor in spontaneously hypertensive rats.
Kang SH; Seok YM; Song MJ; Lee HA; Kurz T; Kim I
Mol Pharmacol; 2015 May; 87(5):782-91. PubMed ID: 25667225
[TBL] [Abstract][Full Text] [Related]
9. The nonepigenetic role for small molecule histone deacetylase inhibitors in the regulation of cardiac function.
Romanick SS; Ferguson BS
Future Med Chem; 2019 Jun; 11(11):1345-1356. PubMed ID: 31161804
[TBL] [Abstract][Full Text] [Related]
10. Lysine acetyltransferases and lysine deacetylases as targets for cardiovascular disease.
Li P; Ge J; Li H
Nat Rev Cardiol; 2020 Feb; 17(2):96-115. PubMed ID: 31350538
[TBL] [Abstract][Full Text] [Related]
11. K-acetylation and its enzymes: overview and new developments.
Aka JA; Kim GW; Yang XJ
Handb Exp Pharmacol; 2011; 206():1-12. PubMed ID: 21879443
[TBL] [Abstract][Full Text] [Related]
12. Acetyl-lysine erasers and readers in the control of pulmonary hypertension and right ventricular hypertrophy.
Stratton MS; McKinsey TA
Biochem Cell Biol; 2015 Apr; 93(2):149-57. PubMed ID: 25707943
[TBL] [Abstract][Full Text] [Related]
13. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention.
Yang XJ; Seto E
Oncogene; 2007 Aug; 26(37):5310-8. PubMed ID: 17694074
[TBL] [Abstract][Full Text] [Related]
14. HDACs and HDAC Inhibitors in Cancer Development and Therapy.
Li Y; Seto E
Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530
[TBL] [Abstract][Full Text] [Related]
15. Chemical and structural biology of protein lysine deacetylases.
Yoshida M; Kudo N; Kosono S; Ito A
Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(5):297-321. PubMed ID: 28496053
[TBL] [Abstract][Full Text] [Related]
16. The biology and therapeutic implications of HDACs in the heart.
McKinsey TA
Handb Exp Pharmacol; 2011; 206():57-78. PubMed ID: 21879446
[TBL] [Abstract][Full Text] [Related]
17. Targeting the acetylation signaling pathway in cancer therapy.
Dang F; Wei W
Semin Cancer Biol; 2022 Oct; 85():209-218. PubMed ID: 33705871
[TBL] [Abstract][Full Text] [Related]
18. Regulation of acetylation restores proteolytic function of diseased myocardium in mouse and human.
Wang D; Fang C; Zong NC; Liem DA; Cadeiras M; Scruggs SB; Yu H; Kim AK; Yang P; Deng M; Lu H; Ping P
Mol Cell Proteomics; 2013 Dec; 12(12):3793-802. PubMed ID: 24037710
[TBL] [Abstract][Full Text] [Related]
19. Functions and mechanisms of plant histone deacetylases.
Chen X; Ding AB; Zhong X
Sci China Life Sci; 2020 Feb; 63(2):206-216. PubMed ID: 31879846
[TBL] [Abstract][Full Text] [Related]
20. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.
Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S
PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
